Middle East & Africa Liquid Biopsy Market to 2032
Overview
The Middle East & Africa Liquid Biopsy Market is expected to reach a 152.94 USD Billion by 2032 and is projected to grow at a CAGR of 16.04% from 2025 to 2032.
Revenue, 2024 (USD Billion)
59.41
Forecast, 2032 (USD Billion)
152.94
CAGR, 2024 - 2032
16.04%
Report Coverage
Middle East & Africa
Middle East & Africa Liquid Biopsy Market 2018-2032 USD Billion
Middle East & Africa Liquid Biopsy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 59.41 USD Billion
- Projected Market Size (2032): 152.94 USD Billion
- CAGR (2025-2032): 16.04%
Key Findings of Middle East & Africa Liquid Biopsy Market
- The Middle East & Africa Liquid Biopsy Market was valued at 59.41 USD Billion in 2024.
- The Middle East & Africa Liquid Biopsy Market is likely to grow at a CAGR of 16.04% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Multi-Gene-Parallel Analysis in Technology Segment accounted for the largest share of the market with a revenue of 50.30 USD Billion
- The fastest growing segment Circulating Tumor Cells (CTCS) in Biomaker Segment grew Fastest with a CAGR of 17.54% during the forecast period from 2024 to 2032.
Middle East & Africa Liquid Biopsy Market Scope
Middle East & Africa Liquid Biopsy Market Segmentation & Scope
Product
- Services & Software
- Instruments
- Consumables & Accessories
Biomaker
- Others
- Extracellular Vesicles
- Exosomes
- Cell-Free RNA
- Circulating Cell-Free DNA (CFDNA)
- Circulating Tumor Cells (CTCS)
Distribution Channel
- Others
- Third Party Distributor
- Direct Tender
End User
- Others
- Research Centres and Academic Institutes
- Diagnostics Centers
- Reference Laboratories
- Hospitals
Analytical
- Histology/Imaging
- Proteomic
- Molecular
Application
- Non-Cancer Applications
- Cancer Applications
Sample
- Others
- Saliva & Other Tissue Fluids Sample-Based
- Urine Sample-Based
- Blood Sample-Based
Technology
- Single Gene Analysis
- Multi-Gene-Parallel Analysis
Clinical Application
- Others
- Patient Work-Up
- Recurrence Monitoring
- Treatment Monitoring
- Therapy Selection
- Routine Screening
Middle East & Africa Liquid Biopsy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 59.41 USD Billion |
| Market Value in 2032 | 152.94 USD Billion |
| CAGR (2025-2032) | 16.04% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product,Biomaker,Distribution Channel,End User,Analytical,Application,Sample,Technology,Clinical Application |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 59.41 USD Billion in 2024
- Key Country: South Africa, leading in terms of revenue with value of 24.79 USD Billion in 2024.
Segments and Scope
-
Middle East & Africa Liquid Biopsy Market to 2032, By Product
- Consumables & Accessories is the largest segment in Middle East & Africa Liquid Biopsy Market to 2032 with a revenue of 40.07 USD Billion in the year 2024.
- Consumables & Accessories is the Fastest growing segment in Middle East & Africa Liquid Biopsy Market to 2032 with a Growth rate of 16.51 % in forecast period 2025-2032.
-
Middle East & Africa Liquid Biopsy Market to 2032, By Biomaker
- Circulating Tumor Cells (CTCS) is the largest segment in Middle East & Africa Liquid Biopsy Market to 2032 with a revenue of 34.29 USD Billion in the year 2024.
- Circulating Tumor Cells (CTCS) is the Fastest growing segment in Middle East & Africa Liquid Biopsy Market to 2032 with a Growth rate of 17.54 % in forecast period 2025-2032.
-
Middle East & Africa Liquid Biopsy Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Middle East & Africa Liquid Biopsy Market to 2032 with a revenue of 45.61 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in Middle East & Africa Liquid Biopsy Market to 2032 with a Growth rate of 16.38 % in forecast period 2025-2032.
-
Middle East & Africa Liquid Biopsy Market to 2032, By End User
- Hospitals is the largest segment in Middle East & Africa Liquid Biopsy Market to 2032 with a revenue of 41.86 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in Middle East & Africa Liquid Biopsy Market to 2032 with a Growth rate of 16.82 % in forecast period 2025-2032.
-
Middle East & Africa Liquid Biopsy Market to 2032, By Analytical
- Molecular is the largest segment in Middle East & Africa Liquid Biopsy Market to 2032 with a revenue of 41.66 USD Billion in the year 2024.
- Proteomic is the Fastest growing segment in Middle East & Africa Liquid Biopsy Market to 2032 with a Growth rate of 16.45 % in forecast period 2025-2032.
-
Middle East & Africa Liquid Biopsy Market to 2032, By Application
- Cancer Applications is the largest segment in Middle East & Africa Liquid Biopsy Market to 2032 with a revenue of 50.15 USD Billion in the year 2024.
- Cancer Applications is the Fastest growing segment in Middle East & Africa Liquid Biopsy Market to 2032 with a Growth rate of 16.29 % in forecast period 2025-2032.
-
Middle East & Africa Liquid Biopsy Market to 2032, By Sample
- Blood Sample-Based is the largest segment in Middle East & Africa Liquid Biopsy Market to 2032 with a revenue of 40.85 USD Billion in the year 2024.
- Blood Sample-Based is the Fastest growing segment in Middle East & Africa Liquid Biopsy Market to 2032 with a Growth rate of 16.71 % in forecast period 2025-2032.
-
Middle East & Africa Liquid Biopsy Market to 2032, By Technology
- Multi-Gene-Parallel Analysis is the largest segment in Middle East & Africa Liquid Biopsy Market to 2032 with a revenue of 50.30 USD Billion in the year 2024.
- Multi-Gene-Parallel Analysis is the Fastest growing segment in Middle East & Africa Liquid Biopsy Market to 2032 with a Growth rate of 16.32 % in forecast period 2025-2032.
-
Middle East & Africa Liquid Biopsy Market to 2032, By Clinical Application
- Routine Screening is the largest segment in Middle East & Africa Liquid Biopsy Market to 2032 with a revenue of 35.17 USD Billion in the year 2024.
- Routine Screening is the Fastest growing segment in Middle East & Africa Liquid Biopsy Market to 2032 with a Growth rate of 17.45 % in forecast period 2025-2032.
Middle East & Africa Liquid Biopsy Market Company Share Analysis
| Company Name |
|
||
| Thermo Fisher Scientific Inc. | |||
| QIAGEN | |||
| Guardant Health | |||
| Exact Sciences Corporation | |||
| F. Hoffmann-La Roche Ltd. | |||
Middle East & Africa Liquid Biopsy Market Geographical Sales Distribution, 2018-2032 USD Billion
Middle East & Africa Liquid Biopsy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Middle East & Africa Liquid Biopsy Market is segmented based on Segmentation Product,Biomaker,Distribution Channel,End User,Analytical,Application,Sample,Technology,Clinical Application.
Middle East & Africa Liquid Biopsy Market was valued at USD 59.41(Revenue in USD Billion) in 2021.
Middle East & Africa Liquid Biopsy Market is projected to grow at a CAGR of 16.04% during the forecast period of 2024 to 2032.
The Multi-Gene-Parallel Analysis segment is expected to dominate the Middle East & Africa Liquid Biopsy Market, holding a largest market share of 50.30 USD Billion in 2024
Middle East & Africa Liquid Biopsy Market Scope
Middle East & Africa Liquid Biopsy Market Segmentation & Scope
Product
- Services & Software
- Instruments
- Consumables & Accessories
Biomaker
- Others
- Extracellular Vesicles
- Exosomes
- Cell-Free RNA
- Circulating Cell-Free DNA (CFDNA)
- Circulating Tumor Cells (CTCS)
Distribution Channel
- Others
- Third Party Distributor
- Direct Tender
End User
- Others
- Research Centres and Academic Institutes
- Diagnostics Centers
- Reference Laboratories
- Hospitals
Analytical
- Histology/Imaging
- Proteomic
- Molecular
Application
- Non-Cancer Applications
- Cancer Applications
Sample
- Others
- Saliva & Other Tissue Fluids Sample-Based
- Urine Sample-Based
- Blood Sample-Based
Technology
- Single Gene Analysis
- Multi-Gene-Parallel Analysis
Clinical Application
- Others
- Patient Work-Up
- Recurrence Monitoring
- Treatment Monitoring
- Therapy Selection
- Routine Screening
Frequently Asked Questions
The Middle East & Africa Liquid Biopsy Market is segmented based on Segmentation Product,Biomaker,Distribution Channel,End User,Analytical,Application,Sample,Technology,Clinical Application.
Middle East & Africa Liquid Biopsy Market was valued at USD 59.41(Revenue in USD Billion) in 2021.
Middle East & Africa Liquid Biopsy Market is projected to grow at a CAGR of 16.04% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Liquid Biopsy Market for final year is USD 152.94 (USD Billion).
Middle East & Africa Liquid Biopsy Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Liquid Biopsy Market is segmented based on Segmentation Product,Biomaker,Distribution Channel,End User,Analytical,Application,Sample,Technology,Clinical Application.
Middle East & Africa Liquid Biopsy Market was valued at USD 59.41(Revenue in USD Billion) in 2021.
Middle East & Africa Liquid Biopsy Market is projected to grow at a CAGR of 16.04% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Liquid Biopsy Market for final year is USD 152.94 (USD Billion).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.